MPP Strikes Landmark Licensing Deal With Novartis On Nilotinib
Agreement On Tasigna Generics Represents First Such Deal For A Cancer Medicine
• By David Wallace
Novartis has signed a voluntary licensing deal with the MPP for nilotinib • Source: Shutterstock 
